The outcome of pregnancy in Kell alloimmunisation

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 107, Issue 4, 2000, Pages 481-485

  Grant, S R ^a   Kilby, M D ^a   Meer, L ^a   Weaver, J B ^a   Gabra, G S ^b   Whittle, M J ^a  

^a BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

^b NBS Birmingham Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADOLESCENT; ADULT; ALLOIMMUNITY; ALLOIMMUNIZATION; AMNIOCENTESIS; AMNION FLUID; ANEMIA; ANTIBODY TITER; ARTICLE; BIRTH WEIGHT; BLOOD GROUP KELL SYSTEM; BLOOD TRANSFUSION; COMPARATIVE STUDY; CORDOCENTESIS; DATA BASE; DISEASE SEVERITY; FEMALE; FETUS; FETUS OUTCOME; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIZATION; STATISTICAL ANALYSIS; UNITED KINGDOM;

ADOLESCENT; ADULT; ANEMIA, NEONATAL; BIRTH WEIGHT; BLOOD GROUP INCOMPATIBILITY; ENGLAND; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; KELL BLOOD-GROUP SYSTEM; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 0034117898     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2000.tb13266.x     Document Type: Article

References (18)

1. Clarke C, Mollison P, Whitefield A. Deaths from rhesus haemolytic disease in England and Wales in 1984–1985. BMJ 1987; 294: 1001.
2. Clarke C, Mollison P. Deaths from rhesus haemolytic disease of fetus and newborn, 1977–1987. J R Coll Physcians Land 1989; 23: 181–184.
3. Vaughan J, Warwick R, Letsky E, Nicolini U, Rodeck C, Fisk N. Ery-thropoietic suppression in fetal anaemia because of Kell alloimmunization. Am J Obstet Gynecol 1994; 171: 247–252.
4. Vaughan J, Manning M, Warwick R, Letsky E, Murray N, Roberts I. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 1998; 338: 798–803.
5. Caine M, Mueller-Heubach E. Kell sensitization in pregnancy. Am J Obstet Gynecol 1986; 154: 85–90.
6. Leggat H, Gibson J, Barren S, Reid M. Anti-Kell in pregnancy. Br J Obstet Gynaecol 1991; 98:162–165.
7. Farr V, Gray E. Pregnancy outcome in mothers who develop Kell antibodies. Scot Med J 1988; 33: 300–303.
8. Birkenfeld A, Yaffe H, Sadovsky E. Sinusoidal fetal heart rate pattern with severe fetal anaemia. Br J Obstet Gynaecol 1980; 87: 916–920.
9. Polesky HF. Blood group antibodies in prenatal sera. Minn Med 1967; 50: 601–603.
10. Weinstein L. Irregular antibodies causing hemolytic disease of the newborn. Obstet Gynecol Surv 1976; 31: 581–591.
11. Walker W. Haemolytic disease of the newborn. In: Gairdner D, Hull D, editors. Recent Advances in Paediatrics. London: Churchill, 1971: 119–170.
12. Bowman JM, Pollock JM, Manning FA, Harman CR, Menticoglou SM. Maternal Kell blood group alloimmunization. Obstet Gynecol 1992; 79: 239–244.
13. Pepperell RJ, Barrie JU, Fliegner JR. Significance of red-cell irregular antibodies in the obstetric patient. Med J Aust 1977; 2: 453–456.
14. McKenna DS, Nagaraja HN, O'Shaugnessy R. Management of pregnancies complicated by anti-Kell isoimmunization. Obstet Gynecol 1999; 93:667–673.
15. Copel J, Scioscia A, Grannum P, Romero R, Reece E, Hobbins J. Percutaneous umbilical blood sampling in the management of Kell isoimmunization. Obstet Gynecol 1986; 67: 288–290.
16. Berkowitz R, Hobbins J. Intrauterine transfusion utilizing ultrasound. Obstet Gynecol 1981; 57: 33–36.
17. Harman C, Manning F, Bowman J et al. Use of intravascular transfusion to treat hydrops fetalis in a moribund fetus. CMA J 1988; 138: 827–830.
18. Menticoglou S, Harman C, Manning F et al. Intraperitoneal transfusion: paralysis inhibits red cell absorption. Fetal Therapy 1987; 2: 154–159.